Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1977 May;11(5):821–825. doi: 10.1128/aac.11.5.821

Renal Pharmacology of Netilmicin

Peter J S Chiu 1, George H Miller 1, Arthur D Brown 1, James F Long 1, J Allan Waitz 1
PMCID: PMC352082  PMID: 879737

Abstract

Netilmicin (Sch 20569), a new semisynthetic aminoglycoside, was studied for its effects on kidney function and mechanisms by which it is handled by the kidneys. Measurements of glomerular filtration rate (GFR) and urinalysis in chronic rat studies indicated that the nephrotoxicity of netilmicin was remarkably less than that of gentamicin. Gentamicin caused a dose-related reduction in GFR in association with glucosuria and elevated fractional excretion of K+. By contrast, high doses of netilmicin produced only slight reduction in GFR with increased fractional excretion of K+ but without glucosuria. In separate experiments, rats were shown to excrete 71 to 90% of netilmicin or gentamicin in 24 h after daily intramuscular administration of doses of 20 or 40 mg/kg for 4 days. In acute experiments on anesthetized dogs, GFR and renal plasma flow were unaffected at serum levels of 11.0 ± 0.6 μg/ml maintained by constant infusion of netilmicin for 5 h. The renal clearance of netilmicin was significantly correlated with GFR. The urinary output of netilmicin was 80.0 ± 4.2% of the infusion rate and was independent of urine flow over the range of 0.04 to 0.33 ml/kg per min. Preferential accumulation of netilmicin occurred in the renal cortex; the cortex–serum and medulla–serum ratios were 9.9 ± 1.2 and 4.2 ± 0.6, respectively. In addition, the extraction ratio of netilmicin, which was lower than that of inulin, suggested that netilmicin reabsorption occurs in the proximal tubule and results in cortical accumulation. It is concluded that netilmicin, like gentamicin, is excreted by the dog kidney by glomerular filtration plus limited reabsorption. However, the new drug is characterized by low intrinsic nephrotoxicity in rats.

Full text

PDF
821

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bergan T., Brodwall E. K., Oyri A. Renal excretion of gentamycin in chronic pyelonephritis. Acta Med Scand. 1971 Jan-Feb;189(1-2):1–5. doi: 10.1111/j.0954-6820.1971.tb04332.x. [DOI] [PubMed] [Google Scholar]
  2. Cabana B. E., Taggart J. G. Comparative pharmacokinetics of BB-K8 and kanamycin in dogs and humans. Antimicrob Agents Chemother. 1973 Apr;3(4):478–483. doi: 10.1128/aac.3.4.478. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Chiu P. J., Brown A., Miller G., Long J. F. Renal extraction of gentamicin in anesthetized dogs. Antimicrob Agents Chemother. 1976 Aug;10(2):277–282. doi: 10.1128/aac.10.2.277. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Clarke J. T., Libke R. D., Regamey C., Kirby W. M. Comparative pharmacokinetics of amikacin and kanamycin. Clin Pharmacol Ther. 1974 Jun;15(6):610–616. doi: 10.1002/cpt1974156610. [DOI] [PubMed] [Google Scholar]
  5. Gordon R. C., Regamey C., Kirby W. M. Serum protein binding of the aminoglycoside antibiotics. Antimicrob Agents Chemother. 1972 Sep;2(3):214–216. doi: 10.1128/aac.2.3.214. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. JAO R. L., JACKSON G. G. GENTAMICIN SULFATE, NEW ANTIBIOTIC AGAINST GRAM-NEGATIVE BACILLI. LABORATORY, PHARMACOLOGICAL, AND CLINICAL EVALUATION. JAMA. 1964 Sep 14;189:817–822. doi: 10.1001/jama.1964.03070110019004. [DOI] [PubMed] [Google Scholar]
  7. Kosek J. C., Mazze R. I., Cousins M. J. Nephrotoxicity of gentamicin. Lab Invest. 1974 Jan;30(1):48–57. [PubMed] [Google Scholar]
  8. Luft F. C., Kleit S. A. Renal parenchymal accumulation of aminoglycoside antibiotics in rats. J Infect Dis. 1974 Dec;130(6):656–659. doi: 10.1093/infdis/130.6.656. [DOI] [PubMed] [Google Scholar]
  9. Luft F. C., Patel V., Yum M. N., Patel B., Kleit S. A. Experimental aminoglycoside nephrotoxicity. J Lab Clin Med. 1975 Aug;86(2):213–220. [PubMed] [Google Scholar]
  10. Naumann P., Auwärter W. Pharmakologische und therapeutische Eigenschaften von Gentamycin. Experimentelle Studien über Wirkstoffspiegel, Ausscheidung, Stabilität und therapeutische Indikationen. Arzneimittelforschung. 1968 Sep;18(9):1119–1123. [PubMed] [Google Scholar]
  11. Ramirez-Ronda C. H., Holmes R. K., Sanford J. P. Effects of divalent cations on binding of aminoglycoside antibiotics to human serum proteins and to bacteria. Antimicrob Agents Chemother. 1975 Mar;7(3):239–245. doi: 10.1128/aac.7.3.239. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Regamey C., Gordon R. C., Kirby W. M. Comparative pharmacokinetics of tobramycin and gentamicin. Clin Pharmacol Ther. 1973 May-Jun;14(3):396–403. doi: 10.1002/cpt1973143396. [DOI] [PubMed] [Google Scholar]
  13. Stone W. J., Bryant R. E., Hoyumpa A., Schenker S. Renal neomycin excretion in the dog. Proc Soc Exp Biol Med. 1974 Mar;145(3):1074–1080. doi: 10.3181/00379727-145-37956. [DOI] [PubMed] [Google Scholar]
  14. Tune B. M. Relationship between the transport and toxicity of cephalosporins in the kidney. J Infect Dis. 1975 Aug;132(2):189–194. doi: 10.1093/infdis/132.2.189. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES